Coronavirus company news summary – Five DOD locations to participate in AstraZeneca Covid-19 Phase III trial

4 September 2020 (Last Updated September 4th, 2020 09:13)

The Tennessee National Guard has reached Covid-19 testing milestone with more than 300,000 administered since March. Out of the total, over 50,000 Covid-19 tests were administered to the most vulnerable populations. The guard’s soldiers and airmen are working alongside Tennessee’s Department of Health, Tennessee Emergency Management Agency, and various other state and local agencies. Testing is being carried out at remote Assessment sites. The number of sites has increased to 21 and are spread across the state’s three grand divisions.

A Spanish military hospital is being re-built to treat Covid-19 as the country readies to fight a possible resurgence of the virus this winter, reported The Olive Press. The Vigil de Quinones Military Hospital is located in Sevilla and was closed about 15 years ago. The Government is planning to stand up the hospital by the end of January next year. It has allocated €117m for hospitals’ improvements. The six-storey hospital will be equipped with 150 beds and 27 intensive care beds.

The Pentagon has announced that five Department of Defense (DOD) locations will take part in AstraZeneca’s Covid-19 vaccine Phase III trial. The vaccine candidate AZD1222 is under development. the selected sites are Naval Medical Center San Diego, Joint Base San Antonio Brooke Army Medical Center, Wilford Hall Ambulatory Surgical Center, Walter Reed National Military Medical Center, and Fort Belvoir Community Hospital. The participation is part of the Operation Warp Speed’s (OWS) aim to deliver safe and effective vaccines and therapeutics by January 2021.